KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Gains from Investment Securities (2019 - 2025)

Inovio Pharmaceuticals (INO) has disclosed Gains from Investment Securities for 12 consecutive years, with $22.5 million as the latest value for Q3 2025.

  • Quarterly Gains from Investment Securities changed N/A to $22.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $24.4 million through Dec 2025, up 975.35% year-over-year, with the annual reading at -$2.8 million for FY2024, 41.56% up from the prior year.
  • Gains from Investment Securities hit $22.5 million in Q3 2025 for Inovio Pharmaceuticals, up from $1.9 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $22.5 million in Q3 2025 to a low of -$3.9 million in Q3 2021.
  • Historically, Gains from Investment Securities has averaged $1.1 million across 5 years, with a median of -$472604.5 in 2022.
  • Biggest five-year swings in Gains from Investment Securities: surged 104695.5% in 2021 and later tumbled 598.91% in 2023.
  • Year by year, Gains from Investment Securities stood at -$3.9 million in 2021, then surged by 104.87% to $190839.0 in 2022, then crashed by 598.91% to -$952113.0 in 2023, then crashed by 192.68% to -$2.8 million in 2024, then soared by 907.98% to $22.5 million in 2025.
  • Business Quant data shows Gains from Investment Securities for INO at $22.5 million in Q3 2025, $1.9 million in Q2 2025, and -$482.0 in Q1 2025.